Sort   by:  
 Page size 
The purpose of the Australian ICGC Pancreatic Cancer Genome Sequencing Initiative study is to identify the common driving mutations underlying the initiation and development of Pancreatic Adenocarcinoma in a large cohort of pancreatic cancer patients (n=350). Matched genome sequences will be generat...
BLUEPRINT DNA methylation profiles of monocytes, neutrophils and T cells from healthy donors
OICR PANCREATIC CANCER DATASET
OICR PANCREATIC CANCER DATASET 2
RNAseq on Illumina HiSeq2000/2500 of PDO culture derived from colorectal cancer metastasis sample at early/late passages
BLUEPRINT DNA methylation profiles of monocytes, T cells and B cells in type 1 diabetes-discordant monozygotic twins

Pancreatic ductal adenocarcinomas (PDAC) is the 11th most common cancer in the USA but the 4th in fatalities. The onset and progression of cancer is driven by extensive rearrangement and mutation of the genome. We combined our capability to capture and enrich exome DNA with the next generation se...

Whole-genome sequencing on Illumina HiSeq2000/2500 of Blood EDTA
Whole-genome sequencing on Illumina HiSeq2000/2500 of Blood EDTA (OT2_cohort)
Whole-exome sequencing on AB 5500xl Genetic Analyzer of Blood EDTA
Sort   by:  
 Page size